On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives

Schnyder, Jenny L.; Jong, Hanna K. de; Bache, Emmanuel B.; Hest, Reinier M. van; Schlagenhauf, Patricia; Borrmann, Steffen; Hanscheid, Thomas; Grobusch, Martin P.

dc.contributor.author	Borrmann, Steffen
dc.contributor.author	Grobusch, Martin
dc.date.accessioned	2023-05-22T14:43:54Z
dc.date.available	2023-05-22T14:43:54Z
dc.date.issued	2023
dc.identifier.issn	1477-8939
dc.identifier.uri	http://hdl.handle.net/10900/141321
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.tmaid.2022.102520	de_DE
dc.subject.ddc	300	de_DE
dc.subject.ddc	610	de_DE
dc.title	On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230202000000_00083
utue.personen.roh	Schnyder, Jenny L.
utue.personen.roh	Jong, Hanna K. de
utue.personen.roh	Bache, Emmanuel B.
utue.personen.roh	Hest, Reinier M. van
utue.personen.roh	Schlagenhauf, Patricia
utue.personen.roh	Borrmann, Steffen
utue.personen.roh	Hanscheid, Thomas
utue.personen.roh	Grobusch, Martin P.
dcterms.isPartOf.ZSTitelID	Travel Medicine and Infectious Disease	de_DE
dcterms.isPartOf.ZS-Issue	Article 102520	de_DE
dcterms.isPartOf.ZS-Volume	52	de_DE